Aim-To use high field proton nuclear magnetic resonance spectroscopy (1H NMR) to characterise the low molecular weight metabolite composition ofneonatal and fetal urine in relation to gestational age and perinatal outcome. Methods-The first urine passed by two neonatal groups, six full term and five preterm infants with normal renal function, was analysed by 1H NMR and compared with fetal urine from 14 cases with obstructive uropathy. Results-The mean ratios of taurine, myo-inositol, and trimethylamine-Noxide (TMAO) to creatinine were 4*3, 101, and 14*1 times higher, respectively, in the preterm group when compared with those of the full term group. Fetal obstructive uropathy was characterised by glycosuria, amino and organic aciduria, regardless of gestational age (13-30 weeks). Conclusions-Samples of the first urine passed -that is, urine produced in fetal life -by normal preterm infants are useful controls for cases of obstructive uropathy detected in the third timester. 1H NMR will become a clinically useful tool for monitoring renal development and abnormalities in utero. (Arch Dis Child 1995; 73: F153-F157) 
The study of fetal renal development has major implications for understanding the aetiology of renal disorders in later life. 1 The stages of development of normal renal function -that is, glomerular filtration and tubular reabsorption and secretion -remain poorly defined. Furthermore, there is little biochemical information relating to renal functional impairment associated with fetal obstructive uropathies.24
The lack of information on the time related changes of endogenous low molecular weight metabolites (such as amino acids, organic acids, amines and sugars) in human fetal urine is a reflection of both the limitations of the conventional analytical techniques used and the difficulty in obtaining normal urine in utero.
1H NMR provides extensive information on both the structure and composition of low molecular weight metabolites in biological fluids and is a powerful, non-invasive, technique for exploring abnormal metabolic and toxicological processes.5 6 Human biofluids give characteristic 1H NMR 'fingerprints' of metabolites that are affected by the basic mechanism, severity, and location of a pathological lesion.5-'3 An important advantage of 'H NMR in the exploration of abnormal biochemistry is that metabolite pre-selection is not required, thereby eliminating a priori judgments by the investigator. Measurement time is short, less than 10 minutes for a standard one dimensional 'H NMR experiment. Small sample volumes (-0 5 ml) can be used; this is an important pre-requisite for fetal and neonatal monitoring, and the unaltered sample can be further investigated by conventional methods. As such, 'H NMR analysis of body fluids (including urine, blood plasma, and cerebrospinal fluid) has become of value in the clinical diagnosis and monitoring of inherited metabolic diseases,'1-13 and the study of the biochemical environment of the fetus. '4 15 In this preliminary study we used high field The notable differences between the 'H NMR detected metabolite profiles of urine from pre-and full term infants are identified in fig 1B, which shows the spectral region 8 3 0 to 8 4-2 of the 'H NMR spectrum of urine from a pre-term infant (gestational age 33 weeks). The large resonance of the N-CH3 group ofTMAO at 8 3-27 was overlapped with that of betaine at physiological pH. Acidification of the sample resulted in a characteristic shift to high frequency of the signal supporting the assignment to that of TMAO.16 Betaine also gives a singlet for the N-CH2 protons at 8 3-91 which was chosen for metabolite quantitation because of minimal peak overlap with other species. Quantitative analysis of the 'H NMR data showed that the excretion profiles of taurine, myo-inositol, and TMAO were higher in the pre-term group than the full term group (table  1) . For comparison, the corresponding ratio for betaine is also given.
The 'H NMR spectra of urine from the group with fetal obstructive uropathy were significantly different from those of the two control neonatal groups. The partial 500 MHz 'H NMR spectra of urine collected from one fetus in group 3 (30 weeks' gestation) and one fetus in group 1 (18 weeks' gestation) are shown in figs 2A and B, respectively. In Table 1 22 Urinary concentrations of TMAO are increased in patients with renal allograft dysfunction, and it has been suggested that TMAO may be a marker of renal medullary damage.8 23 The results of this study lead to the hypothesis that urinary taurine, mycinositol, and TMAO are novel biochemical markers of medullary function in the human fetal kidney. Given that the excretion of these compounds was related to gestational age, we suggest that preterm infants would serve as useful controls for the evaluation of the later stages of normal fetal renal development. We emphasise, however, that it is the first urine passed -that is, urine produced during fetal life -that carries this important biochemical information and once feeding has been initiated the osmolyte composition changes accordingly.
Fetal obstructive uropathy is characterised by both functional and pathological changes caused by obstruction to the flow of urine and is associated with poor perinatal outcome. [2] [3] [4] The assessment of renal function in utero is vital to determine prognosis and initiate appropriate treatment. The biochemical monitoring of fetal renal dysfunction is currently limited to the measurement of urine osmolality and electrolytes, including sodium and Ca2+, but interpretation of the results is controversial.2A The monitoring of obstructive uropathy in utero is, however, dependent on an understanding of normal fetal renal physiology in relation to gestational age. Due to the limited availability of normal fetal urine, the maturation of the fetal nephron and its function has largely been determined from changes in the volume and biochemistry of amniotic fluid. These are dependent on fetal micturition from 20 weeks of gestation. (fig 2A) was significantly different in terms of glucose and amino acid composition from the preterm urines of similar gestational age. These observations confirm that samples of the first urine passed by normal preterm infants are useful controls for cases of obstructive uropathy detected in the third trimester. 1H NMR spectroscopy provides a range of biochemical information that is not available with any other single analytical technique. Used in parallel with conventional clinical chemistry and histopathology 1H NMR analysis of body fluids (such as urine, blood plasma, and cerebrospinal fluid) will increase our understanding of the biochemical basis of a wide range of disease processes. The close collaboration between clinicians and basic NMR scientists will lead, ultimately, to the widespread use of 'H NMR in the clinical research laboratory. In this study we have shown that high field 1H NMR based urinalysis studies are highly appropriate to the investigation of renal development in utero and in the assessment of fetal renal abnormalities and, as such, will become an important clinical diagnostic tool in the future.
